NFKB1 and inflammatory breast carcinoma: The 756 genes-based molecular signature was subjected to a detailed analysis, revealing the presence of several NF-κB target genes and upstream activators of the NF-κB signalling pathway, with strong expression in IBC as compared to non-IBC (Van Laere et al, 2005).